相关文章
Related Articles详细介绍
www.agrenvec.com
Agrenvec是一家专业生产哺乳动物重组蛋白及抗体的欧洲生物技术企业。采用非转基因植物生产出高度复杂的三维结构的重组蛋白,这些植物源的的抗体,不与其他哺乳动物蛋白的产生交叉反应。
Agrenvec的平台技术的基础上使用来自转基因植物病毒的的病毒载体。经过FPLC纯化的蛋白质具有翻译后修饰,至少97%的纯度,100%的活性,并*排除动物源污染。
我们还利用这些植物产生的蛋白质生产抗体,因此这些抗体无脊椎动物的背景信号。
我们可以产生蛋白质的量从微克级到克级,以满足不同研究客户和商业客户的需要。
Recombinant Proteins (重组蛋白)
RF003-2.5 r Human TGF β 2 Active 重组人类转化生长因子β2 活性
RF004-2.5 r Human TGF β 3 Active 重组人类转化生长因子β3 活性
RF0010-5 r Human ACTIVIN A Active 重组人活化素A 活性
RF001-2.5 r Human TGF β 重组人类转化生长因子β
RF009-10 r Human ACTIVIN A 重组人活化素A
RF007-100 r Human TFPI-2 domain 1 重组人TFPI-2结构域1
RF0019-5 r Human LXR β-LBD 重组人LXR β-LBD
Antibodies (抗体)
RF0013-1 IgG Rabbit Polyclonal to Human Interferon α 2a 抗人干扰素α2A
RF0014-50 IgG Rabbit Polyclonal to Human HGH (Somatotropin) 抗人生长激素
RF0015-50 IgG Rabbit Polyclonal to Human TGF β2 抗人转化生长因子β2
RF0016-50 IgG Rabbit Polyclonal to Human ACTIVIN A 抗人活化素A
RF0017-100 IgG Rabbit Polyclonal to Human BMP 7 抗人BMP7
RF0012-100 IgG Rabbit Polyclonal to Human TFPI-2 抗人TFPI- 2
RF0020-100 IgG Rabbit Polyclonal to Human LXR β 抗人LXRβ
RF0022-100 IgG Rabbit Polyclonal to Human Myostatin 抗人肌肉生长抑制素
RF0016-1 | IgG Rabbit Polyclonal to Human | 1mg | 11700 | Agrenvec |
RF0016 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0017-1 | IgG Rabbit Polyclonal to Human | 1mg | 9000 | Agrenvec |
RF0017 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0014-1 | IgG Rabbit Polyclonal to Human | 1mg | 11700 | Agrenvec |
RF0014 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0013-1 | IgG Rabbit Polyclonal to Human | 1mg | 11700 | Agrenvec |
RF0013 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0020-1 | IgG Rabbit Polyclonal to Human | 1mg | 9000 | Agrenvec |
RF0020 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0022-1 | IgG Rabbit Polyclonal to Human | 1mg | 9000 | Agrenvec |
RF0022 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0012-1 | IgG Rabbit Polyclonal to Human | 1mg | 9000 | Agrenvec |
RF0012 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0015-1 | IgG Rabbit Polyclonal to Human | 1mg | 11700 | Agrenvec |
RF0015 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF0018-1 | IgG Rabbit Polyclonal to Human | 1mg | 11700 | Agrenvec |
RF0018 | IgG Rabbit Polyclonal to Human | 100ug | 1800 | Agrenvec |
RF009-1 | r Human ACTIVIN A | 1mg | 36000 | Agrenvec |
RF009-10 | r Human ACTIVIN A | 10ug | 1800 | Agrenvec |
RF009-5 | r Human ACTIVIN A | 5ug | 1080 | Agrenvec |
RF0010-1 | r Human ACTIVIN A Active | 1mg | 54000 | Agrenvec |
RF0010-10 | r Human ACTIVIN A Active | 10ug | 2700 | Agrenvec |
RF0010-5 | r Human ACTIVIN A Active | 5ug | 1440 | Agrenvec |
RF0026-10 | r Human BMP-7 | 10ug | 1800 | Agrenvec |
RF0027-50 | r Human BMP-7 Active | 50ug | 9000 | Agrenvec |
RF0027-5 | r Human BMP-7 Active | 5ug | 1800 | Agrenvec |
RF0027-2.5 | r Human BMP-7 Active | 2.5ug | 1080 | Agrenvec |
RF0019-1 | r Human LXR beta-LBD | 1mg | 45000 | Agrenvec |
RF0019-100 | r Human LXR beta-LBD | 100ug | 13500 | Agrenvec |
RF0019-50 | r Human LXR beta-LBD | 50ug | 9000 | Agrenvec |
RF0019-25 | r Human LXR beta-LBD | 25ug | 5400 | Agrenvec |
RF0019-10 | r Human LXR beta-LBD | 10ug | 2700 | Agrenvec |
RF0019-5 | r Human LXR beta-LBD | 5ug | 1440 | Agrenvec |
RF007-1 | r Human TFPI-2 domain 1 | 1mg | 5400 | Agrenvec |
RF001-1 | r Human TGF beta 2 | 1mg | 45000 | Agrenvec |
RF001-5 | r Human TGF beta 2 | 5ug | 1800 | Agrenvec |
RF001-2.5 | r Human TGF beta 2 | 2.5ug | 1080 | Agrenvec |
RF003-1 | r Human TGF beta 2 Active | 1mg | 63000 | Agrenvec |
RF003-5 | r Human TGF beta 2 Active | 5ug | 2700 | Agrenvec |
RF003-2.5 | r Human TGF beta 2 Active | 2.5ug | 1440 | Agrenvec |
RF002-1 | r Human TGF beta 3 | 1mg | 45000 | Agrenvec |
RF002-5 | r Human TGF beta 3 | 5ug | 1800 | Agrenvec |
RF002-2.5 | r Human TGF beta 3 | 2.5ug | 1080 | Agrenvec |
RF004-1 | r Human TGF beta 3 Active | 1mg | 63000 | Agrenvec |
RF004-5 | r Human TGF beta 3 Active | 5ug | 2700 | Agrenvec |
RF004-2.5 | r Human TGF beta 3 Active | 2.5ug | 1440 | Agrenvec |
产品咨询
电话
QQ咨询
4006551678